Sol Gel Tech Financials
Sol Gel Tech (SLGL) reported $19.4M in revenue for fiscal year 2025, up 68.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Sol-Gel’s cash profile is now shaped more by collaboration-style funding than by a fully profitable underlying business.
FY2025 marks a cash-conversion break: operating cash flow improved by about$14.2M to$322K even though the company still reported a loss. Because R&D spend remained above revenue at$22.8M , that cash turn looks tied more to payment timing or milestone economics than to the core cost base becoming self-funding.
Cash fell from
This remains an asset-light R&D operation, not a business consuming cash to build physical capacity: capital spending was only
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Sol Gel Tech's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Sol Gel Tech scores 11.52, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($260.1M) relative to total liabilities ($7.1M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Sol Gel Tech passes 5 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.
Sol Gel Tech reported a net loss of $6.1M while generating $322K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Sol Gel Tech generated $19.4M in revenue in fiscal year 2025. This represents an increase of 68.0% from the prior year.
Sol Gel Tech's EBITDA was -$7.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 36.9% from the prior year.
Sol Gel Tech reported -$6.1M in net income in fiscal year 2025. This represents an increase of 42.1% from the prior year.
Cash & Balance Sheet
Sol Gel Tech generated $275K in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 102.0% from the prior year.
Sol Gel Tech held $11.0M in cash as of fiscal year 2025; long-term debt is not reported for that period.
Not reported for fiscal year 2025.
Margins & Returns
Sol Gel Tech's operating margin was -38.9% in fiscal year 2025, reflecting core business profitability. No change is given against fiscal year 2024: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Sol Gel Tech's net profit margin was -31.6% in fiscal year 2025, showing the share of revenue converted to profit. This is up 60.1 percentage points from the prior year.
Sol Gel Tech's ROE was -26.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 9.8 percentage points from the prior year.
Not reported for fiscal year 2025.
Capital Allocation
Sol Gel Tech invested $22.8M in research and development in fiscal year 2025. This represents an increase of 28.1% from the prior year.
Sol Gel Tech invested $47K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 2250.0% from the prior year.
Not reported for fiscal year 2025.
SLGL Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q4'25 | Q2'25 | Q4'24 | Q2'24 | Q4'23 | Q2'23 | Q4'22 | Q2'22 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | $17.3M | N/A | $5.4M | N/A | $594K | N/A | $3.5M |
| R&D Expenses | N/A | $4.6M | N/A | $2.4M | N/A | $5.3M | N/A | $2.4M |
| SG&A Expenses | N/A | $1.4M | N/A | $1.4M | N/A | $1.8M | N/A | $1.6M |
| Operating Income | N/A | $11.2M | N/A | $1.6M | N/A | -$6.5M | N/A | -$463K |
| Net Income | N/A | $11.6M | N/A | $2.0M | N/A | -$6.0M | N/A | -$134K |
| EPS (Diluted) | N/A | $4.17 | N/A | $0.71 | N/A | -$0.22 | N/A | $0.01 |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, Interest Expense, Income Tax.
SLGL Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q4'25 | Q2'25 | Q4'24 | Q2'24 | Q4'23 | Q2'23 | Q4'22 | Q2'22 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $29.9M-23.9% | $39.3M+9.7% | $35.8M-14.7% | $42.0M-7.2% | $45.3M-17.8% | $55.1M+18.2% | $46.6M-15.2% | $55.0M |
| Current Assets | $27.0M-25.6% | $36.3M+15.9% | $31.3M-18.3% | $38.3M-7.0% | $41.2M-20.2% | $51.6M+19.8% | $43.1M-11.2% | $48.5M |
| Cash & Equivalents | $11.0M+7.9% | $10.2M-47.6% | $19.5M+68.8% | $11.5M+53.7% | $7.5M-51.9% | $15.6M+25.5% | $12.4M+115.9% | $5.8M |
| Accounts Receivable | $2.0M-80.4% | $10.0M+179.3% | $3.6M-40.7% | $6.1M+1507.2% | $377K | N/A | $62K | N/A |
| Total Liabilities | $7.1M-4.3% | $7.4M+6.1% | $7.0M-1.5% | $7.1M+6.9% | $6.6M-2.4% | $6.8M+54.2% | $4.4M-4.7% | $4.6M |
| Current Liabilities | $6.2M+24.5% | $5.0M-6.2% | $5.3M+1.6% | $5.2M+15.0% | $4.5M-20.2% | $5.7M+70.2% | $3.3M+3.2% | $3.2M |
| Total Equity | $22.8M-28.5% | $31.9M+10.5% | $28.9M-17.3% | $34.9M-9.7% | $38.6M-20.0% | $48.3M+14.4% | $42.2M-16.2% | $50.4M |
| Retained Earnings | -$237.0M-3.9% | -$228.1M+1.2% | -$230.9M-2.8% | -$224.7M-2.0% | -$220.3M-5.0% | -$209.8M-8.6% | -$193.1M+8.0% | -$209.8M |
Not reported in any period shown, so not listed: Inventory, Goodwill, Long-Term Debt.
SLGL Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q4'25 | Q2'25 | Q4'24 | Q2'24 | Q4'23 | Q2'23 | Q4'22 | Q2'22 |
|---|
Not reported in any period shown, so not listed: Operating Cash Flow, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.
SLGL Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | Q4'25 | Q2'25 | Q4'24 | Q2'24 | Q4'23 | Q2'23 | Q4'22 | Q2'22 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | N/A | 65.1% | N/A | 29.9% | N/A | -1098.8% | N/A | -13.2% |
| Net Margin | N/A | 67.3% | N/A | 36.4% | N/A | -1005.0% | N/A | -3.8% |
| Return on Equity | N/A | 36.4% | N/A | 5.7% | N/A | -12.4% | N/A | -0.3% |
| Return on Assets | N/A | 29.5% | N/A | 4.7% | N/A | -10.8% | N/A | -0.2% |
| Current Ratio | 4.37-2.9x | 7.32+1.4x | 5.92-1.4x | 7.36-1.7x | 9.100.0x | 9.10-3.8x | 12.93-2.1x | 15.03 |
| Debt-to-Equity | 0.31+0.1x | 0.230.0x | 0.240.0x | 0.200.0x | 0.170.0x | 0.140.0x | 0.100.0x | 0.09 |
Not reported in any period shown, so not listed: Gross Margin, FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.
Similar Companies
Where Sol Gel Tech Ranks
Frequently Asked Questions
What is Sol Gel Tech's annual revenue?
Sol Gel Tech (SLGL) reported $19.4M in total revenue for fiscal year 2025. This represents a 68.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Sol Gel Tech's revenue growing?
Sol Gel Tech (SLGL) revenue grew by 68.0% year-over-year, from $11.5M to $19.4M in fiscal year 2025.
Is Sol Gel Tech profitable?
No, Sol Gel Tech (SLGL) reported a net income of -$6.1M in fiscal year 2025, with a net profit margin of -31.6%.
What is Sol Gel Tech's EBITDA?
Sol Gel Tech (SLGL) had EBITDA of -$7.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Sol Gel Tech's operating margin?
Sol Gel Tech (SLGL) had an operating margin of -38.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Sol Gel Tech's net profit margin?
Sol Gel Tech (SLGL) had a net profit margin of -31.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Sol Gel Tech's return on equity (ROE)?
Sol Gel Tech (SLGL) has a return on equity of -26.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Sol Gel Tech's free cash flow?
Sol Gel Tech (SLGL) generated $275K in free cash flow during fiscal year 2025. This represents a 102.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Sol Gel Tech's operating cash flow?
Sol Gel Tech (SLGL) generated $322K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Sol Gel Tech's total assets?
Sol Gel Tech (SLGL) had $29.9M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Sol Gel Tech's capital expenditures?
Sol Gel Tech (SLGL) invested $47K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Sol Gel Tech spend on research and development?
Sol Gel Tech (SLGL) invested $22.8M in research and development during fiscal year 2025.
What is Sol Gel Tech's current ratio?
Sol Gel Tech (SLGL) had a current ratio of 4.37 as of fiscal year 2025, which is generally considered healthy.
What is Sol Gel Tech's debt-to-equity ratio?
Sol Gel Tech (SLGL) had a debt-to-equity ratio of 0.31 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Sol Gel Tech's return on assets (ROA)?
Sol Gel Tech (SLGL) had a return on assets of -20.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Sol Gel Tech's Altman Z-Score?
Sol Gel Tech (SLGL) has an Altman Z-Score of 11.52, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Sol Gel Tech's Piotroski F-Score?
Sol Gel Tech (SLGL) has a Piotroski F-Score of 5 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Sol Gel Tech's earnings high quality?
Sol Gel Tech (SLGL) reported a net loss of $6.1M while generating $322K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Sol Gel Tech?
Sol Gel Tech (SLGL) scores 91 out of 100 on our Financial Health Score, indicating strong standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.